RxSight Inc (RXST) posted $24.6 million in Q3 2026 revenue amid competitive and internal disruption, while completing a restructuring and advancing its Alcon partnership and next-gen lens pipeline.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight’s common stock to the same employees in
RxSight (RXST) has upside potential if it executes salesforce expansion and utilization-growth initi
Detailed price information for Rxsight Inc (RXST-Q) from The Globe and Mail including charting and trades.
RxSight (RXST) has an average rating of hold and mean price target of $7.57, according to analysts p
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. ET in Boston, Massachusetts. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/. About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providin
This is the newest page. Registered accounts read further back.